5935 N Jensen St Las Vegas NV 89149
Lost Colony Botanicals is a startup wholesaler of hemp-derived cannabidiol (CBD) isolate and distillate.
Lost Colony will purchase and grow raw hemp biomass and perform the extraction and refinement of crude oils to create these wholesale commodities. Unlike the majority of producers in this newly legal and fragmented market, Lost Colony will operate at an industrial scale and employ current good manufacturing practices (cGMP) to get ahead of prospective regulations and realize substantial cost advantages. This will allow Lost Colony to position itself as the low-cost leader within the rapidly growing industry. The founder has extensive expertise in CBD production in addition to having acted as a public company CFO and senior appointee to the Nevada State Controller’s Office, where he oversaw financial reporting on more than $17 billion in annual transactions. He has already scaled one CBD business on the West Coast which was sold at a substantial gain to investors.
Geoffrey Lawrence is formerly the senior appointee to the State of Nevada Controller’s Office, where he oversaw the state’s external financial reporting covering $17 billion in annual transactions. He has also acted as Chief Financial Officer for private and public companies including the first publicly traded marijuana licensee to be listed on a U.S. exchange.
Mr. Lawrence has broad expertise in public policy, having served as a policy director for the Nevada Assembly Speaker and acting as Director of Drug Policy for the Reason Foundation, a nationwide think tank that helps states implement laws relating to the regulation of hemp and licensed marijuana. For the past year, Mr. Lawrence has acted as CFO of a CBD wholesaler in California, where he managed the company’s private offerings, accounting functions, financial planning and analysis, and earnings distributions.
Mr. Lawrence holds an M.S. and B.S. in Accounting, an M.A. in international economics, and a B.A. in international relations.
Industrial hemp and its extracts, including CBD, were removed from the federal Controlled Substances Act by the 2018 Farm Bill.
This created a new legal market for CBD that has quickly attracted interest. CBD has been proven effective for the treatment of certain epileptic conditions and Harvard Medical School reports that it may also be effective for the treatment of anxiety, insomnia, chronic pain, and inflammation. Consumer demand for CBD-infused products has exploded quickly and market analysts forecast additional growth as CBD is incorporated into cosmetics, health products, food and beverages, pet products, skincare, and pharmaceuticals, to name just a few product categories. BDS Analytics forecasts the U.S. CBD market to grow from $1.9 billion in 2018 to $20 billion by 2024.2 The Brightfield Group anticipates even faster growth, with the market reaching $22 billion by 2022.3 As CBD product offerings grow and expand over the next few years, manufacturers of these products will increasingly need a reliable source of food-grade CBD extracts to include in their formulations.
Lost Colony believes that the most successful CBD products have yet to be developed or marketed successfully.
CBD is a nutritional supplement—akin to a vitamin—that may have significant health benefits for humans. Yet, a majority of CBD products to date have consisted of tinctures or vaping products. Most people don’t vape Vitamin C, for instance. We instead foresee a burgeoning new market for CBD-infused food and beverages once the Food and Drug Administration promulgates rules allowing its inclusion into food products. The FDA is working on these rules now and most major food companies are awaiting those rules to be in place before launching new product lines. Big brands like Coca-Cola, Pepsi and Snapple are considering CBD-infused product lines and are seeking compliant, industrial-scale suppliers that will be able to meet their needs once those rules are promulgated.
Cannabis exhibits many of the characteristics common to emerging markets. These include information opacity, fragmentation, trade barriers, price discovery, value discovery, regulatory uncertainty, and consumer evolution.